Page 29 - 2020 ARE eGuide for Clinical at Hospital Sites
P. 29
2020 Annual Required Education
Anticoagulation Therapy:
Anticoagulation is a high-risk treatment, which commonly leads to adverse
drug events due to the complexity of dosing these medications, monitoring their
effects, and ensuring patient compliance with outpatient therapy.
The use of standardized practices
that include patient involvement can
reduce the risk of adverse drug
events associated with the use of
heparin (unfractionated), low
molecular weight heparin (LMWH),
warfarin, and other anticoagulants.
Patient/family education must
include the importance of follow-up
monitoring, compliance issues,
dietary restrictions, and potential for
adverse drug reactions and
interactions.
